{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T14:16:15Z","timestamp":1790172975248,"version":"4.1.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AG047505"],"award-info":[{"award-number":["AG047505"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003390","name":"Fritz Thyssen Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003390","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.brainres.2018.12.038","type":"journal-article","created":{"date-parts":[[2018,12,26]],"date-time":"2018-12-26T02:22:02Z","timestamp":1545790922000},"page":"125-135","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["PrP-grafted antibodies bind certain amyloid \u03b2-protein aggregates, but do not prevent toxicity"],"prefix":"10.1016","volume":"1710","author":[{"given":"David","family":"Mengel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grant T.","family":"Corbett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"DeSousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Solforosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew P.","family":"Frosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Collinge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic M.","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainres.2018.12.038_b0005","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/j.1471-4159.2011.07613.x","article-title":"The prion protein unstructured N-terminal region is a broad-spectrum molecular sensor with diverse and contrasting potential functions","volume":"120","author":"Beland","year":"2012","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2018.12.038_b0010","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1111\/j.1471-4159.2008.05306.x","article-title":"Non-infectious aggregates of the prion protein react with several PrPSc-directed antibodies","volume":"105","author":"Biasini","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2018.12.038_b0015","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.tins.2011.10.002","article-title":"Prion protein at the crossroads of physiology and disease","volume":"35","author":"Biasini","year":"2012","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.brainres.2018.12.038_b0020","doi-asserted-by":"crossref","unstructured":"Brinkmalm, G., Hong, W., Wang, Z., Liu, W., O\u2018Malley, T., Sun, X., Frosch, M.P., Selkoe, D.J., Portelius, E., Zetterberg, H., Blennow, K., Walsh, D.M., 2018. Identification of neurotoxic cross-linked A\u03b2 dimers in Alzheimer brain. in review.","DOI":"10.1093\/brain\/awz066"},{"key":"10.1016\/j.brainres.2018.12.038_b9000","doi-asserted-by":"crossref","first-page":"3184","DOI":"10.1096\/fj.06-7993com","article-title":"Amyloid-beta reduction by memapsin 2 (beta-secretase) immunization","volume":"21","author":"Chang","year":"2007","journal-title":"FASEB J."},{"key":"10.1016\/j.brainres.2018.12.038_b0025","doi-asserted-by":"crossref","first-page":"26377","DOI":"10.1074\/jbc.M110.145516","article-title":"Interaction between human prion protein and amyloid-b (Ab) oligomers: role of N-terminal residues","volume":"285","author":"Chen","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.brainres.2018.12.038_b0030","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1126\/science.1110837","article-title":"Anchorless prion protein results in infectious amyloid disease without clinical scrapie","volume":"308","author":"Chesebro","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.brainres.2018.12.038_b0035","doi-asserted-by":"crossref","first-page":"13258","DOI":"10.1523\/JNEUROSCI.3109-08.2008","article-title":"Aggregated, wild-type prion protein causes neurological dysfunction and synaptic abnormalities","volume":"28","author":"Chiesa","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2018.12.038_b0040","unstructured":"Corbett, G.T., Asfaw, A., Hall, T.C., Wang, Z., Liu, W., Collinge, J., Perkinton, M., Billinton, A., Walsh, D.M., 2018. A recipe for neurotoxicity: the prion protein, promiscuous binding, and soluble protein aggregates? Society for Neuroscience. Abstract #: 713.02, San Diego."},{"key":"10.1016\/j.brainres.2018.12.038_b0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005623","article-title":"A neuronal culture system to detect prion synaptotoxicity","volume":"12","author":"Fang","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.brainres.2018.12.038_b0050","doi-asserted-by":"crossref","first-page":"7857","DOI":"10.1074\/jbc.M112.423954","article-title":"An N-terminal fragment of the prion protein binds to amyloid-b oligomers and inhibits their neurotoxicity in vivo","volume":"288","author":"Fluharty","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.brainres.2018.12.038_b0055","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/ncomms1341","article-title":"Interaction between prion protein and toxic amyloid \u03b2 assemblies can be therapeutically targeted at multiple sites","volume":"2","author":"Freir","year":"2011","journal-title":"Nat. Commun."},{"key":"10.1016\/j.brainres.2018.12.038_b0060","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00109-009-0568-7","article-title":"Beta-amyloid oligomers and cellular prion protein in Alzheimer\u2019s disease","volume":"88","author":"Gunther","year":"2010","journal-title":"J. Mol. Med. (Berl.)"},{"key":"10.1016\/j.brainres.2018.12.038_b0065","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00401-018-1846-7","article-title":"Diffusible, highly bioactive oligomers represent a critical minority of soluble Abeta in Alzheimer\u2019s disease brain","volume":"136","author":"Hong","year":"2018","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.brainres.2018.12.038_b0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0167-4838(99)00038-2","article-title":"Multiple folding pathways for heterologously expressed human prion protein","volume":"1431","author":"Jackson","year":"1999","journal-title":"Biochim. Biophys. Acta, Gen. Subj."},{"key":"10.1016\/j.brainres.2018.12.038_b0075","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1038\/s41467-018-05068-w","article-title":"An in vitro paradigm to assess potential anti-Abeta antibodies for Alzheimer\u2019s disease","volume":"9","author":"Jin","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.brainres.2018.12.038_b9005","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1073\/pnas.94.4.1550","article-title":"Amyloid precursor protein processing and A beta42 deposition in a transgenic mouse model of Alzheimer disease","volume":"94","author":"Johnson-Wood","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"Suppl. 2","key":"10.1016\/j.brainres.2018.12.038_b0080","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/jnc.13632","article-title":"The amyloid cascade hypothesis: are we poised for success or failure?","volume":"139","author":"Karran","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2018.12.038_b9010","first-page":"121","article-title":"Production and characterization of monoclonal antibodies reactive to synthetic cerebrovascular amyloid peptide","author":"Kim","year":"1988","journal-title":"Neurosci. Res. Commun."},{"key":"10.1016\/j.brainres.2018.12.038_b0085","doi-asserted-by":"crossref","first-page":"11551","DOI":"10.1073\/pnas.0704260104","article-title":"Characterization of prion protein (PrP)-derived peptides that discriminate full-length PrPSc from PrPC","volume":"104","author":"Lau","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.brainres.2018.12.038_b0090","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/nature07761","article-title":"Cellular prion protein mediates impairment of synaptic plasticity by amyloid b oligomers","volume":"457","author":"Lauren","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.brainres.2018.12.038_b0095","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/950783","article-title":"Breaking the code of amyloid-beta oligomers","volume":"2013","author":"Lesne","year":"2013","journal-title":"Int. J. Cell Biol."},{"key":"10.1016\/j.brainres.2018.12.038_b0100","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.nbd.2015.07.008","article-title":"Anti-Abeta antibodies incapable of reducing cerebral Abeta oligomers fail to attenuate spatial reference memory deficits in J20 mice","volume":"82","author":"Mably","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.brainres.2018.12.038_b0105","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.biolcel.2003.11.007","article-title":"Alpha- and beta-cleavages of the amino-terminus of the cellular prion protein","volume":"96","author":"Mange","year":"2004","journal-title":"Biol. Cell"},{"key":"10.1016\/j.brainres.2018.12.038_b0110","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.jalz.2015.01.005","article-title":"The aqueous phase of Alzheimer\u2019s disease brain contains assemblies built from approximately 4 and approximately 7 kDa Abeta species","volume":"11","author":"Mc Donald","year":"2015","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.brainres.2018.12.038_b0115","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1074\/jbc.M113.502351","article-title":"A new paradigm for enzymatic control of alpha-cleavage and beta-cleavage of the prion protein","volume":"289","author":"McDonald","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.brainres.2018.12.038_b0120","doi-asserted-by":"crossref","first-page":"10404","DOI":"10.1073\/pnas.0403522101","article-title":"Motif-grafted antibodies containing the replicative interface of cellular PrP are specific for PrPSc","volume":"101","author":"Moroncini","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.brainres.2018.12.038_b0125","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1038\/ncomms3416","article-title":"Amyloid-beta nanotubes are associated with prion protein-dependent synaptotoxicity","volume":"4","author":"Nicoll","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.brainres.2018.12.038_b0130","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1016\/j.bbadis.2018.03.023","article-title":"Identification of prion protein-derived peptides of potential use in Alzheimer\u2019s disease therapy","volume":"1864","author":"Nieznanska","year":"2018","journal-title":"Biochim. Biophys. Acta, Gen. Subj."},{"key":"10.1016\/j.brainres.2018.12.038_b0135","doi-asserted-by":"crossref","first-page":"33104","DOI":"10.1074\/jbc.C112.400614","article-title":"Soluble prion protein inhibits amyloid-b (Ab) fibrillization and toxicity","volume":"287","author":"Nieznanski","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.brainres.2018.12.038_b0140","doi-asserted-by":"crossref","first-page":"15536","DOI":"10.1074\/jbc.M601349200","article-title":"Probing the conformation of the prion protein within a single amyloid fibril using a novel immunoconformational assay","volume":"281","author":"Novitskaya","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.brainres.2018.12.038_b9015","doi-asserted-by":"crossref","first-page":"10595","DOI":"10.1523\/JNEUROSCI.1700-18.2018","article-title":"Cellular Prion Protein Mediates the Disruption of Hippocampal Synaptic Plasticity by Soluble Tau In Vivo","volume":"38","author":"Ondrejcak","year":"2018","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2018.12.038_b0145","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1042\/BJ20140219","article-title":"Abeta dimers differ from monomers in structural propensity, aggregation paths and population of synaptotoxic assemblies","volume":"461","author":"O'Malley","year":"2014","journal-title":"Biochem. J."},{"key":"10.1016\/j.brainres.2018.12.038_b0150","doi-asserted-by":"crossref","first-page":"6150","DOI":"10.1021\/acs.biochem.6b00453","article-title":"The aggregation paths and products of Abeta42 dimers are distinct from those of the Abeta42 monomer","volume":"55","author":"O'Malley","year":"2016","journal-title":"Biochemistry"},{"key":"10.1016\/j.brainres.2018.12.038_b9020","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1111\/j.1460-9568.2006.04805.x","article-title":"Clearance and prevention of prion infection in cell culture by anti-PrP antibodies","volume":"23","author":"Pankiewicz","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.brainres.2018.12.038_b9025","first-page":"75","article-title":"Blocking the apoE\/A\u03b2 interaction ameliorates A\u03b2-related pathology in APOE \u025b2 and \u025b4 targeted replacement Alzheimer model mice","volume":"2","author":"Pankiewicz","year":"2014","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.brainres.2018.12.038_b0155","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1038\/emboj.2011.86","article-title":"The cellular prion protein mediates neurotoxic signalling of b-sheet-rich conformers independent of prion replication","volume":"30","author":"Resenberger","year":"2011","journal-title":"EMBO J."},{"key":"10.1016\/j.brainres.2018.12.038_b0160","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nature09768","article-title":"Prion propagation and toxicity in vivo occur in two distinct mechanistic phases","volume":"470","author":"Sandberg","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.brainres.2018.12.038_b0165","doi-asserted-by":"crossref","first-page":"4347","DOI":"10.1038\/ncomms5347","article-title":"Prion neuropathology follows the accumulation of alternate prion protein isoforms after infective titre has peaked","volume":"5","author":"Sandberg","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.brainres.2018.12.038_b0170","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/nature02264","article-title":"Folding proteins in fatal ways","volume":"426","author":"Selkoe","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.brainres.2018.12.038_b0175","doi-asserted-by":"crossref","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease at 25 years","volume":"8","author":"Selkoe","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.brainres.2018.12.038_b0180","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/nature03989","article-title":"The most infectious prion protein particles","volume":"437","author":"Silveira","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.brainres.2018.12.038_b0185","first-page":"7","article-title":"Binding sites for amyloid-beta oligomers and synaptic toxicity","author":"Smith","year":"2017","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.brainres.2018.12.038_b0190","doi-asserted-by":"crossref","first-page":"7465","DOI":"10.1074\/jbc.M610051200","article-title":"Toward molecular dissection of PrPC-PrPSc interactions","volume":"282","author":"Solforosi","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.brainres.2018.12.038_b0195","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nrn1007","article-title":"Unfolding the role of protein misfolding in neurodegenerative diseases","volume":"4","author":"Soto","year":"2003","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.brainres.2018.12.038_b0200","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.3233\/JAD-150882","article-title":"The anti-prion antibody 15B3 detects toxic amyloid-beta oligomers","volume":"53","author":"Stravalaci","year":"2016","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.brainres.2018.12.038_b0205","doi-asserted-by":"crossref","first-page":"8817","DOI":"10.1523\/JNEUROSCI.1103-12.2012","article-title":"The N-terminal, polybasic region of PrP(C) dictates the efficiency of prion propagation by binding to PrP(Sc)","volume":"32","author":"Turnbaugh","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2018.12.038_b0210","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1038\/nn.3178","article-title":"Alzheimer amyloid-beta oligomer bound to postsynaptic prion protein activates Fyn to impair neurons","volume":"15","author":"Um","year":"2012","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.brainres.2018.12.038_b0215","doi-asserted-by":"crossref","first-page":"4552","DOI":"10.1021\/acs.analchem.7b04936","article-title":"Direct evidence of the presence of cross-linked Abeta dimers in the brains of Alzheimer\u2019s disease patients","volume":"90","author":"Vazquez de la Torre","year":"2018","journal-title":"Anal. Chem."},{"key":"10.1016\/j.brainres.2018.12.038_b0220","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nrn.2016.13","article-title":"A critical appraisal of the pathogenic protein spread hypothesis of neurodegeneration","volume":"17","author":"Walsh","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.brainres.2018.12.038_b0225","doi-asserted-by":"crossref","first-page":"11947","DOI":"10.1523\/JNEUROSCI.2009-17.2017","article-title":"Human brain-derived Abeta oligomers bind to synapses and disrupt synaptic activity in a manner that requires APP","volume":"37","author":"Wang","year":"2017","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2018.12.038_b0230","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00401-013-1083-z","article-title":"Oligomers, fact or artefact? SDS-PAGE induces dimerization of beta-amyloid in human brain samples","volume":"125","author":"Watt","year":"2013","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.brainres.2018.12.038_b9030","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/nature01457","article-title":"Monoclonal antibodies inhibit prion replication and delay the development of prion disease","volume":"422","author":"White","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.brainres.2018.12.038_b0235","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1096\/fj.12-222588","article-title":"The cellular prion protein traps Alzheimer\u2019s Ab in an oligomeric form and disassembles amyloid fibers","volume":"27","author":"Younan","year":"2013","journal-title":"Federation Am. Soc. Exp. Biol. J."},{"key":"10.1016\/j.brainres.2018.12.038_b0240","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0014-5793(97)01330-6","article-title":"Human prion proteins expressed in Escherichia coli and purified by high-affinity column refolding","volume":"417","author":"Zahn","year":"1997","journal-title":"FEBS Lett."},{"key":"10.1016\/j.brainres.2018.12.038_b0245","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.neuron.2013.05.029","article-title":"Rapid single-step induction of functional neurons from human pluripotent stem cells","volume":"78","author":"Zhang","year":"2013","journal-title":"Neuron"}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899318306644?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899318306644?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T18:02:01Z","timestamp":1757786521000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899318306644"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":56,"alternative-id":["S0006899318306644"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2018.12.038","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PrP-grafted antibodies bind certain amyloid \u03b2-protein aggregates, but do not prevent toxicity","name":"articletitle","label":"Article Title"},{"value":"Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainres.2018.12.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}